Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lerner

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Blood|June 22, 2001
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaS Ibrahim, M Keating, K A Do, et al.
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Leukemia Research|April 27, 2000
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemiaF Ravandi-Kashani, S O'Brien, T Manshouri, et al.
European Journal of Gastroenterology & Hepatology|September 3, 2013
Procedure volume influences adherence to celiac disease guidelinesBenjamin Lebwohl, Robert M Genta, Robert C Kapel, et al.
Journal of Lipid Research|August 1, 1992
Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the ratS Shefer, L B Nguyen, G Salen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab dose-escalation trial in chronic lymphocytic leukemiaS M O'Brien, H Kantarjian, D A Thomas, et al.
Leukemia & Lymphoma|June 1, 1993
Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose scheduleA Kemena, S O'Brien, H Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2016
Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaL Falchi, C Vitale, M J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemiaA Ferrajoli, T Manshouri, Z Estrov, et al.
Hepatology (Baltimore, Md.)|July 1, 1994
The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotesS Shefer, G Salen, J Bullock, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Blood|June 22, 2001
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemiaS Ibrahim, M Keating, K A Do, et al.
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Leukemia Research|April 27, 2000
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemiaF Ravandi-Kashani, S O'Brien, T Manshouri, et al.
European Journal of Gastroenterology & Hepatology|September 3, 2013
Procedure volume influences adherence to celiac disease guidelinesBenjamin Lebwohl, Robert M Genta, Robert C Kapel, et al.
Journal of Lipid Research|August 1, 1992
Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the ratS Shefer, L B Nguyen, G Salen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab dose-escalation trial in chronic lymphocytic leukemiaS M O'Brien, H Kantarjian, D A Thomas, et al.
Leukemia & Lymphoma|June 1, 1993
Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose scheduleA Kemena, S O'Brien, H Kantarjian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2016
Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaL Falchi, C Vitale, M J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemiaA Ferrajoli, T Manshouri, Z Estrov, et al.
Hepatology (Baltimore, Md.)|July 1, 1994
The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotesS Shefer, G Salen, J Bullock, et al.
Pageof 16